115 related articles for article (PubMed ID: 2245573)
1. Heel pad thickness is an insensitive index of biochemical remission in acromegaly.
MacSweeney JE; Baxter MA; Joplin GF
Clin Radiol; 1990 Nov; 42(5):348-50. PubMed ID: 2245573
[TBL] [Abstract][Full Text] [Related]
2. Interstitial pituitary irradiation with 90Y for the treatment of acromegaly. A reappraisal.
Cassar J; Doyle FH; Banks LM; Jadresic A; Mashiter K; Joplin GF
Acta Endocrinol (Copenh); 1981 Mar; 96(3):295-300. PubMed ID: 7211092
[TBL] [Abstract][Full Text] [Related]
3. Lack of rise in serum prolactin following yttrium-90 interstitial irradiation for acromegaly.
Clark AJ; Chahal P; Mashiter K; Joplin GF
Clin Endocrinol (Oxf); 1983 Nov; 19(5):557-63. PubMed ID: 6416717
[TBL] [Abstract][Full Text] [Related]
4. Is soft tissue radiology useful in acromegaly?
Paisey R; Jeans WD; Hartog M
Br J Radiol; 1984 Jul; 57(679):561-4. PubMed ID: 6733402
[TBL] [Abstract][Full Text] [Related]
5. Heel pad thickness in acromegaly.
Kho KM; Wright AD; Doyle FH
Br J Radiol; 1970 Feb; 43(506):119-25. PubMed ID: 5424277
[No Abstract] [Full Text] [Related]
6. Treatment of acromegaly by trans-sphenoidal operation, 90-yttrium implantation and bromocriptine: results in 230 patients.
Quabbe HJ
Clin Endocrinol (Oxf); 1982 Feb; 16(2):107-19. PubMed ID: 7067156
[TBL] [Abstract][Full Text] [Related]
7. Sebum excretion in acromegaly.
Burton JL; Libman LJ; Cunliffe WJ; Wilkinson R; Hall R; Shuster S
Br Med J; 1972 Feb; 1(5797):406-8. PubMed ID: 4333483
[TBL] [Abstract][Full Text] [Related]
8. Postoperative radiotherapy in acromegaly is effective in reducing GH concentration to safe levels.
Biermasz NR; Dulken HV; Roelfsema F
Clin Endocrinol (Oxf); 2000 Sep; 53(3):321-7. PubMed ID: 10971449
[TBL] [Abstract][Full Text] [Related]
9. Long-term effect of 90Y pituitary implantation in acromegaly.
Jadresic A; Jimenez LE; Joplin GF
Acta Endocrinol (Copenh); 1987 Jul; 115(3):301-6. PubMed ID: 3618081
[TBL] [Abstract][Full Text] [Related]
10. Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?
Damjanovic SS; Neskovic AN; Petakov MS; Popovic V; Macut D; Vukojevic P; Joksimovic MM
Clin Endocrinol (Oxf); 2005 Apr; 62(4):410-7. PubMed ID: 15807870
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of acromegaly].
Barceló Lucerga B
Med Clin (Barc); 1985 Feb; 84(6):227-9. PubMed ID: 3982132
[No Abstract] [Full Text] [Related]
12. Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure.
Sheaves R; Jenkins P; Blackburn P; Huneidi AH; Afshar F; Medbak S; Grossman AB; Besser GM; Wass JA
Clin Endocrinol (Oxf); 1996 Oct; 45(4):407-13. PubMed ID: 8959078
[TBL] [Abstract][Full Text] [Related]
13. Serial assays of plasma growth hormone in treated and untreated acromegaly.
Hunter WM; Gillingham FJ; Harris P; Kanis JA; McGurk FM; McLelland J; Strong JA
J Endocrinol; 1974 Oct; 63(1):21-34. PubMed ID: 4417605
[No Abstract] [Full Text] [Related]
14. Skin thickness in patients with acromegaly and Cushing's syndrome and response to treatment.
Ferguson JK; Donald RA; Weston TS; Espiner EA
Clin Endocrinol (Oxf); 1983 Apr; 18(4):347-53. PubMed ID: 6872269
[TBL] [Abstract][Full Text] [Related]
15. Predicting long-term remission by measuring immediate postoperative growth hormone levels and oral glucose tolerance test in acromegaly.
Kim EH; Oh MC; Lee EJ; Kim SH
Neurosurgery; 2012 May; 70(5):1106-13; discussion 1113. PubMed ID: 22067418
[TBL] [Abstract][Full Text] [Related]
16. Criteria for the cure of acromegaly: comparison between basal growth hormone and somatomedin C plasma concentrations in active and non-active acromegalic patients.
Giannella-Neto D; Wajchenberg BL; Mendonça BB; Almeida SF; Macchione M; Spencer EM
J Endocrinol Invest; 1988 Jan; 11(1):57-60. PubMed ID: 3361077
[TBL] [Abstract][Full Text] [Related]
17. Characterization of 24-hour growth hormone secretion in acromegaly: implications for diagnosis and therapy.
Ho KY; Weissberger AJ
Clin Endocrinol (Oxf); 1994 Jul; 41(1):75-83. PubMed ID: 8050134
[TBL] [Abstract][Full Text] [Related]
18. [CLINICAL, BIOCHEMICAL AND HORMONAL PREDICTORS OF LEFT VENTRICULAR HYPERTROPHY IN PATIENTS WITH ACROMEGALY].
Mykytyuk MR
Lik Sprava; 2015; (5-6):34-40. PubMed ID: 27089713
[TBL] [Abstract][Full Text] [Related]
19. Significance of "abnormal" nadir growth hormone levels after oral glucose in postoperative patients with acromegaly in remission with normal insulin-like growth factor-I levels.
Freda PU; Nuruzzaman AT; Reyes CM; Sundeen RE; Post KD
J Clin Endocrinol Metab; 2004 Feb; 89(2):495-500. PubMed ID: 14764751
[TBL] [Abstract][Full Text] [Related]
20. Ultrasonographic evidence of joint thickening reversibility in acromegalic patients treated with lanreotide for 12 months.
Colao A; Marzullo P; Vallone G; Giaccio A; Ferone D; Rossi E; Scarpa R; Smaltino F; Lombardi G
Clin Endocrinol (Oxf); 1999 Nov; 51(5):611-8. PubMed ID: 10594522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
